Junyan Yu

1.4k total citations
19 papers, 141 citations indexed

About

Junyan Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Junyan Yu has authored 19 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Junyan Yu's work include Gastric Cancer Management and Outcomes (4 papers), RNA modifications and cancer (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Junyan Yu is often cited by papers focused on Gastric Cancer Management and Outcomes (4 papers), RNA modifications and cancer (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Junyan Yu collaborates with scholars based in China, Macao and Saudi Arabia. Junyan Yu's co-authors include Xiangyang Tian, Ping Liu, Rong Zhang, Hongzhong Wang, Yandong Zhang, Lulu Li, Rong Zhang, Ping Liu, Ningning Zhang and Ningning Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Food Chemistry and Frontiers in Immunology.

In The Last Decade

Junyan Yu

15 papers receiving 137 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyan Yu China 8 87 57 36 22 16 19 141
Raheleh Amirkhah Iran 8 186 2.1× 152 2.7× 40 1.1× 13 0.6× 18 1.1× 15 254
Yuwen Qi China 8 74 0.9× 66 1.2× 40 1.1× 32 1.5× 32 2.0× 16 158
Huazhen Liang China 6 77 0.9× 52 0.9× 49 1.4× 31 1.4× 6 0.4× 10 152
Yechen Feng China 5 66 0.8× 60 1.1× 39 1.1× 21 1.0× 21 1.3× 11 113
Diana Restifo United States 4 89 1.0× 56 1.0× 59 1.6× 20 0.9× 26 1.6× 8 154
Alejandro M. Cuadros United States 3 127 1.5× 55 1.0× 23 0.6× 21 1.0× 7 0.4× 3 183
Naijie Liu China 7 123 1.4× 88 1.5× 15 0.4× 28 1.3× 5 0.3× 10 191
Diane Bruyère Belgium 4 89 1.0× 38 0.7× 52 1.4× 21 1.0× 20 1.3× 5 194

Countries citing papers authored by Junyan Yu

Since Specialization
Citations

This map shows the geographic impact of Junyan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyan Yu more than expected).

Fields of papers citing papers by Junyan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyan Yu. The network helps show where Junyan Yu may publish in the future.

Co-authorship network of co-authors of Junyan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Junyan Yu. A scholar is included among the top collaborators of Junyan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyan Yu. Junyan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Jin, et al.. (2025). Comparing the effects of unplugged activities and plugged activities on the development of students'computational thinking: a meta-analysis. Educational Technology Research and Development. 73(5). 3247–3267.
2.
3.
Deng, Ting, Yuxian Bai, Tianshu Liu, et al.. (2025). Paclitaxel oral solution versus paclitaxel injection as a second-line therapy in advanced gastric cancer: A randomized, open-label, non-inferiority phase 3 trial.. Journal of Clinical Oncology. 43(4_suppl). 442–442. 1 indexed citations
4.
Yu, Junyan, Lei Xu, Nan Zhang, et al.. (2024). Integrated, high-throughput metabolomics approach for metabolite analysis of four sprout types. Food Chemistry. 463(Pt 2). 141182–141182. 2 indexed citations
5.
6.
7.
Zhang, Rong, Lulu Li, & Junyan Yu. (2024). Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells. Open Life Sciences. 19(1). 20220874–20220874. 12 indexed citations
8.
Wang, Di, et al.. (2023). Recent Advances in Fibrinogen Research in Colorectal Cancer. Journal of Biosciences and Medicines. 11(4). 28–38. 1 indexed citations
9.
Zhang, Miao, Jifang Gong, Jufeng Wang, et al.. (2023). A phase I/II study of ASKB589 (anti-claudin 18.2 [CLDN18.2] monoclonal antibody) in patients with solid tumors.. Journal of Clinical Oncology. 41(4_suppl). 397–397. 11 indexed citations
10.
Tian, Xiangyang, et al.. (2021). MicroRNA‑429 acts as a tumor suppressor in colorectal cancer by targeting high mobility group box 3. Oncology Letters. 21(4). 250–250. 11 indexed citations
11.
Liu, Ping, et al.. (2020). Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum‐Based Chemotherapy in Asian Patients with NSCLC: A Meta‐Analysis. BioMed Research International. 2020(1). 3520764–3520764. 8 indexed citations
12.
Zhang, Ningning, et al.. (2020). Gold nanoparticles synthesized from Curcuma wenyujin inhibits HER-2/neu transcription in breast cancer cells (MDA-MB-231/HER2). Arabian Journal of Chemistry. 13(10). 7264–7273. 14 indexed citations
13.
Zhao, Jian, et al.. (2019). Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma. Investigational New Drugs. 38(2). 500–506. 14 indexed citations
14.
Liu, Ping, Junyan Yu, Xiangyang Tian, et al.. (2018). The effect of downregulation of Stathmin gene on biological behaviors of U373 and U87-MG glioblastoma cells. Biological Research. 51(1). 16–16. 7 indexed citations
15.
Wang, Hongzhong, et al.. (2018). The RNA helicase DHX33 is required for cancer cell proliferation in human glioblastoma and confers resistance to PI3K/mTOR inhibition. Cellular Signalling. 54. 170–178. 22 indexed citations
16.
Bai, Chunmei, Diansheng Zhong, Xiubao Ren, et al.. (2018). Apatinib in patients with adenocarcinoma of stomach or gastroesophageal junction: A prospective, multicenter, non-interventional study (Ahead-G202).. Journal of Clinical Oncology. 36(15_suppl). e16047–e16047.
17.
Bai, Chunmei, Diansheng Zhong, Ruixing Zhang, et al.. (2018). Prospective, multicenter, noninterventional and registry clinical study of apatinib in patients with advanced gastric cancer.. Journal of Clinical Oncology. 36(4_suppl). 137–137. 2 indexed citations
18.
Yu, Junyan, et al.. (2017). RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182/HOXA9. Biomedicine & Pharmacotherapy. 96. 782–791. 31 indexed citations
19.
Liu, Ping, et al.. (2015). Genetic association between CD95 rs2234767 polymorphism and cervical cancer risk: a meta analysis.. PubMed. 8(2). 2357–63. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raheleh Amirkhah Breakdown of academic impact, for papers by Yuwen Qi Breakdown of academic impact, for papers by Huazhen Liang Breakdown of academic impact, for papers by Yechen Feng Breakdown of academic impact, for papers by Diana Restifo Breakdown of academic impact, for papers by Alejandro M. Cuadros Breakdown of academic impact, for papers by Naijie Liu Breakdown of academic impact, for papers by Diane Bruyère
Rankless by CCL
2026